Sale of Yhtyneet Medix Laboratoriot to SYNLAB
(16.07.2018)

Avance advises Medix Laboratoriot and Yhtyneet Laboratoriot in the sale of Finland’s leading private laboratory company Yhtyneet Medix Laboratoriot to SYNLAB. Yhtyneet Medix Laboratoriot offers comprehensive central laboratory services in the fields of clinical chemistry, clinical microbiology, pathology and genetics as well as in therapeutic drug testing, drugs of abuse testing and doping control in sports.

Refinancing of Quattro Mikenti Group
(06.07.2018)

Avance advises Adelis Equity Partners Fund I and Quattro Mikenti Group in connection with the refinancing of Quattro Mikenti Group’s bank facilities.

AddLife acquires Väinö Korpinen Oy
(04.07.2018)

Avance advises AddLife Development AB in the acquisition of Väinö Korpinen Oy. Väinö Korpinen Oy has established itself as the leading supplier of customized bathroom solutions on the Finnish market. All bathroom solutions and products are developed in close cooperation between designers and health care professionals. The target group for the company’s solutions comprises individuals with special needs, including advanced age, people with disabilities and people with dementia.
 
The acquisition fits squarely in with AddLife group’s strategy for continued expansion in the home care sector and comprises an excellent complement to completed acquisitions in the area of home care.

Castellum acquires office property for EUR 81 million
(29.06.2018)

Avance advises Castellum, one of the largest listed real estate companies in Sweden, in its acquisition from Skandia Fastigheter of an office property in the Ruoholahti office-block area of Helsinki. The building of the property comprises some 14,400 sqm with Nokia and Fennovoima as major tenants.

Through the acquisition, Castellum enters the Finnish market and aims to become one of the major commercial real estate owners in Helsinki.